Amy Reyes
Cornerstone therapy in atopic dermatitis
Moisturizers were described as the “cornerstone of therapy” in atopic dermatitis in the 2014 AAD guidelines for topical therapies in atopic dermatitis, but the products differ greatly by ingredients which can improve the condition or make it worse.
Psoriasis patient point of view
Psoriasis patient point of view
Survey highlights the challenges of controlling psoriasis flares.
A squamous cell carcinoma that disproportionately affects men
A squamous cell carcinoma that disproportionately affects men
Factors that drive lip squamous cell carcinomas in men.
Male aesthetic procedures are up, despite little research on procedures in men
Male aesthetic procedures are up, despite little research on procedures in men
While there is an increasing interest among men in cosmetic procedures, there is little research in this area to guide physicians. Experts say that customization is best for tough cases.
Redefining skin cancer staging reveals previously hidden cases
Staging cutaneous squamous cell skin cancer under AJCC-9 reveals more T3 cases.
Atopic dermatitis phenotypes
Atopic dermatitis phenotypes
In this slideshow, we highlight four atopic dermatitis phenotypes in children as described in JAMA Pediatrics.
House dust mites and severe atopic dermatitis: A new connection
Patients with severe atopic dermatitis who have lower serum vitamin D levels have a high sensitivity to house dust mites which can aggravate their condition, a new study shows.
Abatacept: Pricey, but Effective
Abatacept: Pricey, but Effective
The approval of abatacept (Orencia/Bristol-Myers Squibb) for psoriatic arthritis (PsA) earlier this month by the FDA offers a new treatment option for patients who are struggling to keep the disease under control.

Poll

View Results